-+ 0.00%
-+ 0.00%
-+ 0.00%

JP Morgan Maintains Overweight on Relay Therapeutics, Raises Price Target to $31

Benzinga·08/14/2026 16:13:36
Listen to the news
JP Morgan analyst Priyanka Grover maintains Relay Therapeutics (NASDAQ:RLAY) with a Overweight and raises the price target from $28 to $31.